HM Payson & Co’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $79.3K | Hold |
2,330
| – | – | ﹤0.01% | 560 |
|
|
2024
Q4 | $91.7K | Hold |
2,330
| – | – | ﹤0.01% | 545 |
|
|
2024
Q3 | $109K | Buy |
2,330
+1,250
| +116% | +$58.7K | ﹤0.01% | 510 |
|
|
2024
Q2 | $58.3K | Hold |
1,080
| – | – | ﹤0.01% | 574 |
|
|
2024
Q1 | $73.6K | Buy |
1,080
+100
| +10% | +$6.82K | ﹤0.01% | 547 |
|
|
2023
Q4 | $61.3K | Hold |
980
| – | – | ﹤0.01% | 556 |
|
|
2023
Q3 | $44.5K | Hold |
980
| – | – | ﹤0.01% | 602 |
|
|
2023
Q2 | $55K | Hold |
980
| – | – | ﹤0.01% | 562 |
|
|
2023
Q1 | $44.3K | Hold |
980
| – | – | ﹤0.01% | 596 |
|
|
2022
Q4 | $39.8K | Buy |
980
+500
| +104% | +$20.3K | ﹤0.01% | 587 |
|
|
2022
Q3 | $31K | Buy |
480
+400
| +500% | +$25.8K | ﹤0.01% | 635 |
|
|
2022
Q2 | $5K | Hold |
80
| – | – | ﹤0.01% | 883 |
|
|
2022
Q1 | $5K | Hold |
80
| – | – | ﹤0.01% | 908 |
|
|
2021
Q4 | $6K | Sell |
80
-25
| -24% | -$1.88K | ﹤0.01% | 919 |
|
|
2021
Q3 | $12K | Buy |
105
+28
| +36% | +$3.2K | ﹤0.01% | 815 |
|
|
2021
Q2 | $12K | Buy |
77
+42
| +120% | +$6.55K | ﹤0.01% | 803 |
|
|
2021
Q1 | $4K | Buy |
+35
| New | +$4K | ﹤0.01% | 963 |
|